Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
Gynecologic Oncology
|
September 10, 1999
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma
F D Cirisano, S J Robboy, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures
F J Xu, Y H Yu, L Daly, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancer
A Berchuck, G J Olt, A P Soisson, et al.
American Journal of Obstetrics and Gynecology
|
September 11, 1991
Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines
F L Tyson, C M Boyer, R Kaufman, et al.
Gynecologic Oncology
|
February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors
A Berchuck, M F Kohler, M P Hopkins, et al.
Cancer
|
April 1, 1994
OVX1 as a marker for early stage endometrial carcinoma
F J Xu, Y H Yu, L Daly, et al.
Cancer Research
|
August 1, 1986
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors
K S McCarty, E Szabo, J L Flowers, et al.
Journal of the National Cancer Institute
|
September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
M F Kohler, J R Marks, R W Wiseman, et al.
Gynecologic Oncology
|
April 15, 2014
Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?
K M Doll, A C Snavely, A Kalinowski, et al.
Journal of the National Cancer Institute
|
November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancer
R P Woolas, F J Xu, I J Jacobs, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
Gynecologic Oncology
|
September 10, 1999
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma
F D Cirisano, S J Robboy, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures
F J Xu, Y H Yu, L Daly, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancer
A Berchuck, G J Olt, A P Soisson, et al.
American Journal of Obstetrics and Gynecology
|
September 11, 1991
Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines
F L Tyson, C M Boyer, R Kaufman, et al.
Gynecologic Oncology
|
February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors
A Berchuck, M F Kohler, M P Hopkins, et al.
Cancer
|
April 1, 1994
OVX1 as a marker for early stage endometrial carcinoma
F J Xu, Y H Yu, L Daly, et al.
Cancer Research
|
August 1, 1986
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors
K S McCarty, E Szabo, J L Flowers, et al.
Journal of the National Cancer Institute
|
September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
M F Kohler, J R Marks, R W Wiseman, et al.
Gynecologic Oncology
|
April 15, 2014
Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?
K M Doll, A C Snavely, A Kalinowski, et al.
Journal of the National Cancer Institute
|
November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancer
R P Woolas, F J Xu, I J Jacobs, et al.
Page
of 13